These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25026028)

  • 41. Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus.
    Richaud-Patin Y; Pérez-Romano B; Carrillo-Maravilla E; Rodriguez AB; Simon AJ; Cabiedes J; Jakez-Ocampo J; Llorente L; Ruiz-Argüelles A
    Immunol Lett; 2003 Aug; 88(2):95-9. PubMed ID: 12880676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The complement regulatory proteins CD55 (decay accelerating factor) and CD59 are expressed on the inner acrosomal membrane of human spermatozoa as well as CD46 (membrane cofactor protein).
    Cummerson JA; Flanagan BF; Spiller DG; Johnson PM
    Immunology; 2006 Jul; 118(3):333-42. PubMed ID: 16827894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneity of F cells in β-thalassemia.
    Prus E; Fibach E
    Transfusion; 2013 Mar; 53(3):499-504. PubMed ID: 22738617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
    Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).
    Spear GT; Lurain NS; Parker CJ; Ghassemi M; Payne GH; Saifuddin M
    J Immunol; 1995 Nov; 155(9):4376-81. PubMed ID: 7594597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surface expression of complement regulatory proteins, decay-accelerating factor (DAF) and CD59, on cultured human endothelial cells.
    Kunii H; Shichishima T; Saitoh Y; Noji H; Maruyama Y
    Fukushima J Med Sci; 1998 Dec; 44(2):69-81. PubMed ID: 10091379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered Expression Levels of CD59, but Not CD55, on Red Blood Cells in Stored Blood.
    Al-Faris L; Al-Humood S
    Med Princ Pract; 2019; 28(4):361-366. PubMed ID: 30844815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diminished presentation of complement regulatory protein CD55 on red blood cells from patients with hereditary haemolytic anaemias.
    Loniewska-Lwowska A; Koza K; Mendek-Czajkowska E; Wieszczy P; Adamowicz-Salach A; Branicka K; Witos I; Sapala-Smoczynska A; Jackowska T; Fabijanska-Mitek J
    Int J Lab Hematol; 2018 Apr; 40(2):128-135. PubMed ID: 28963754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients.
    Zahedpanah M; Azarkeivan A; Aghaieepour M; Nikogoftar M; Ahmadinegad M; Hajibeigi B; Tabatabaiee MR; Maghsudlu M
    Hematology; 2014 Dec; 19(8):472-6. PubMed ID: 24620948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: relation to pulmonary hypertension and aortic wall stiffness.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM
    Eur J Haematol; 2013 Jun; 90(6):508-18. PubMed ID: 23506251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anaemia & expression levels of CD35, CD55 & CD59 on red blood cells in Plasmodium falciparum malaria patients from India.
    Mahajan RC; Narain K; Mahanta J
    Indian J Med Res; 2011 Jun; 133(6):662-4. PubMed ID: 21727667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased nitrite levels in erythrocytes of children with β-thalassemia/hemoglobin E.
    Suvachananonda T; Wankham A; Srihirun S; Tanratana P; Unchern S; Fucharoen S; Chuansumrit A; Sirachainan N; Sibmooh N
    Nitric Oxide; 2013 Sep; 33():1-5. PubMed ID: 23680525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unraveling the C-reactive protein complement-cascade in destruction of red blood cells: potential pathological implications in Plasmodium falciparum malaria.
    Ansar W; Habib SK; Roy S; Mandal C; Mandal C
    Cell Physiol Biochem; 2009; 23(1-3):175-90. PubMed ID: 19255512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density.
    Voskaridou E; Ntanasis-Stathopoulos I; Christoulas D; Dimopoulou M; Komninaka V; Repa K; Papatheodorou A; Terpos E
    Ann Hematol; 2019 Jul; 98(7):1583-1592. PubMed ID: 31041514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia.
    Romanello KS; Teixeira KKL; Silva JPMO; Nagamatsu ST; Bezerra MAC; Domingos IF; Martins DAP; Araujo AS; Lanaro C; Breyer CA; Ferreira RA; Franco-Penteado C; Costa FF; Malavazi I; Netto LES; de Oliveira MA; Cunha AF
    PLoS One; 2018; 13(12):e0208316. PubMed ID: 30521599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Phosphatidylserine-Exposing Red Blood Cells, Fragmented Red Blood Cells and Red Blood Cell-Derived Microparticles in β-Thalassemia/HbE Patients.
    Noulsri E; Ardsiri S; Lerdwana S; Pattanapanyasat K
    Lab Med; 2019 Jan; 50(1):47-53. PubMed ID: 30016461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran.
    Haghpanah S; Vahdati S; Karimi M
    Hemoglobin; 2017 May; 41(3):169-174. PubMed ID: 28741988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluating viscoelastic properties and membrane electrical charges of red blood cells with optical tweezers and cationic quantum dots - applications to β-thalassemia intermedia hemoglobinopathy.
    Lima CN; Moura DS; Silva YSS; Souza TH; Crisafuli FAP; Silva DCN; Peres JC; Cesar CL; de Araujo RE; Fontes A
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110671. PubMed ID: 31816460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Storage of RBCs results in an increased susceptibility for complement-mediated degradation.
    Kamhieh-Milz J; Bartl B; Sterzer V; Kamhieh-Milz S; Salama A
    Transfus Med; 2014 Dec; 24(6):392-9. PubMed ID: 25492040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients.
    Youssry I; Soliman N; Ghamrawy M; Samy RM; Nasr A; Abdel Mohsen M; ElShahaat M; Bou Fakhredin R; Taher A
    Ann Hematol; 2017 Apr; 96(4):597-603. PubMed ID: 28168351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.